![Cynthia Shumate](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cynthia Shumate
Keine laufenden Positionen mehr
Profil
Cynthia Shumate has been Secretary, Chief Compliance Officer and Vice President-Legal Affairs of PDL BioPharma, Inc. since October 2006.
She was Vice President-Intellectual Property of PDL BioPharma from September 2006 to April 2004.
Previously, Ms. Shumate was Senior Director and Associate General Counsel, Intellectual Property at Corixa Corporation from 1998 to 2004.
.
Prior to Corixa, she was a Patent Attorney at Cell Therapeutics, Inc. from 1997 to 1998 and NeoRx Corporation from 1993 to 1997.
Ms. Shumate received a JD degree from The John Marshall Law School, Chicago and a Bachelor's degree in Biology from Western Washington University at Bellingham.
Ehemalige bekannte Positionen von Cynthia Shumate
| Unternehmen | Position | Ende |
|---|---|---|
| PDL BIOPHARMA, INC. | General Counsel | 01.01.2008 |
Protein Design Labs, Inc.
 Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops humanized monoclonal antibodies | Corporate Officer/Principal | 10.01.2006 |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Develops and manufactures oncology and immunology products | Direktor/Vorstandsmitglied | 01.01.2005 |
| CTI BIOPHARMA CORP. | General Counsel | 01.01.1998 |
| PONIARD PHARMACEUTICALS, INC. | General Counsel | 01.01.1997 |
Ausbildung von Cynthia Shumate
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
77
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Poniard Pharmaceuticals, Inc.
 Poniard Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops therapeutic biopharmaceuticals, primarily for the treatment of cancer, cardiovascular and inflammatory diseases | Health Technology |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops humanized monoclonal antibodies | Health Technology |
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Develops and manufactures oncology and immunology products | Health Technology |
John Marshall Law School (Georgia)
 John Marshall Law School (Georgia) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Western Washington University
 Western Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that manufactures and wholesales prescription medicine products | Health Technology |
